Copyright
©The Author(s) 2023.
World J Gastroenterol. May 28, 2023; 29(20): 3103-3118
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3103
Published online May 28, 2023. doi: 10.3748/wjg.v29.i20.3103
Table 2 Content of secondary structural analysis from DSSP method
| Structure | Coil | β-Sheet | β-Bridge | Bend | Turn | 3-Helix |
| TGFβR2 | 0.58 | 0.3 | 0.42 | 0.02 | 0.12 | 0.13 |
| TGFβR2-DHE | 0.56 | 0.3 | 0.42 | 0.02 | 0.12 | 0.12 |
- Citation: Zheng KX, Yuan SL, Dong M, Zhang HL, Jiang XX, Yan CL, Ye RC, Zhou HQ, Chen L, Jiang R, Cheng ZY, Zhang Z, Wang Q, Jin WZ, Xie W. Dihydroergotamine ameliorates liver fibrosis by targeting transforming growth factor β type II receptor. World J Gastroenterol 2023; 29(20): 3103-3118
- URL: https://www.wjgnet.com/1007-9327/full/v29/i20/3103.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i20.3103